Sunflower Pharmaceutical GroupLtd 将来の成長
Future 基準チェック /06
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sunflower Pharmaceutical GroupLtd.
主要情報
n/a
収益成長率
n/a
EPS成長率
| Pharmaceuticals 収益成長 | 19.3% |
| 収益成長率 | n/a |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | None |
| 最終更新日 | n/a |
今後の成長に関する最新情報
更新なし
Recent updates
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)
Aug 26
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E
Jul 19Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 07Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders
May 06Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity
Apr 16We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease
Mar 04このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Sunflower Pharmaceutical GroupLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。
シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 9/30/2024 | 4,432 | 855 | -15 | 103 | N/A |
| 6/30/2024 | 5,194 | 967 | 254 | 372 | N/A |
| 3/31/2024 | 5,453 | 968 | 718 | 845 | N/A |
| 12/31/2023 | 5,700 | 1,119 | 741 | 890 | N/A |
| 9/30/2023 | 6,100 | 1,209 | 1,436 | 1,582 | N/A |
| 6/30/2023 | 5,879 | 1,104 | 1,711 | 1,859 | N/A |
| 3/31/2023 | 5,662 | 1,054 | 1,670 | 1,794 | N/A |
| 1/1/2023 | 5,095 | 867 | 1,822 | 1,975 | N/A |
| 9/30/2022 | 4,675 | 813 | 1,112 | 1,252 | N/A |
| 6/30/2022 | 4,608 | 799 | 749 | 908 | N/A |
| 3/31/2022 | 4,443 | 698 | 925 | 1,075 | N/A |
| 1/1/2022 | 4,461 | 705 | 747 | 865 | N/A |
| 9/30/2021 | 4,271 | 668 | 775 | 914 | N/A |
| 6/30/2021 | 3,964 | 655 | 978 | 1,166 | N/A |
| 3/31/2021 | 3,769 | 656 | 930 | 1,143 | N/A |
| 12/31/2020 | 3,462 | 584 | 957 | 1,170 | N/A |
| 9/30/2020 | 3,427 | 509 | 886 | 1,184 | N/A |
| 6/30/2020 | 3,585 | 497 | 699 | 1,012 | N/A |
| 3/31/2020 | 4,069 | 557 | 698 | 1,052 | N/A |
| 12/31/2019 | 4,371 | 565 | 607 | 981 | N/A |
| 9/30/2019 | 4,488 | 591 | 684 | 1,028 | N/A |
| 6/30/2019 | 4,523 | 586 | 700 | 1,013 | N/A |
| 3/31/2019 | 4,594 | 580 | 538 | 882 | N/A |
| 12/31/2018 | 4,472 | 563 | 545 | 866 | N/A |
| 9/30/2018 | 4,369 | 524 | 578 | 820 | N/A |
| 6/30/2018 | 4,234 | 515 | N/A | 639 | N/A |
| 3/31/2018 | 4,111 | 472 | N/A | 689 | N/A |
| 12/31/2017 | 3,855 | 424 | N/A | 567 | N/A |
| 9/30/2017 | 3,855 | 426 | N/A | 490 | N/A |
| 6/30/2017 | 3,785 | 328 | N/A | 524 | N/A |
| 3/31/2017 | 3,435 | 305 | N/A | 230 | N/A |
| 12/31/2016 | 3,364 | 303 | N/A | 341 | N/A |
| 9/30/2016 | 3,045 | 230 | N/A | -71 | N/A |
| 6/30/2016 | 3,057 | 291 | N/A | -111 | N/A |
| 3/31/2016 | 3,094 | 319 | N/A | 93 | N/A |
| 12/31/2015 | 3,035 | 307 | N/A | 126 | N/A |
| 9/30/2015 | 2,981 | 307 | N/A | 211 | N/A |
| 6/30/2015 | 2,980 | 319 | N/A | 382 | N/A |
| 3/31/2015 | 2,820 | 312 | N/A | 421 | N/A |
| 12/31/2014 | 2,719 | 301 | N/A | 403 | N/A |
| 9/30/2014 | 2,567 | 268 | N/A | 425 | N/A |
| 12/31/2013 | 2,181 | 263 | N/A | 293 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: Insufficient data to determine if 002737's forecast earnings growth is above the savings rate (2.9%).
収益対市場: Insufficient data to determine if 002737's earnings are forecast to grow faster than the CN market
高成長収益: Insufficient data to determine if 002737's earnings are expected to grow significantly over the next 3 years.
収益対市場: Insufficient data to determine if 002737's revenue is forecast to grow faster than the CN market.
高い収益成長: Insufficient data to determine if 002737's revenue is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if 002737's Return on Equity is forecast to be high in 3 years time